Selected research
Industry Research
Biomarker Discovery Outsourcing Services Industry Research Report 2026
Market perspective
The global Biomarker Discovery Outsourcing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biomarker Discovery Outsourcing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biomarker Discovery Outsourcing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biomarker Discovery Outsourcing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biomarker Discovery Outsourcing Services include Laboratory Corporation of America Holdings, GHO Capital, ICON plc, Agilent, Proteome Sciences, Charles River Laboratories., Eurofins Scientific, Celerion and Evotec and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biomarker Discovery Outsourcing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomarker Discovery Outsourcing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomarker Discovery Outsourcing Services Market by Company
Laboratory Corporation of America Holdings
GHO Capital
ICON plc
Agilent
Proteome Sciences
Charles River Laboratories.
Eurofins Scientific
Celerion
Evotec
Parexel International (MA) Corporation
Biomarker Discovery Outsourcing Services Segment by Type
Predictive biomarkers
Safety biomarkers
Prognostic biomarkers
Others
Biomarker Discovery Outsourcing Services Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
Biomarker Discovery Outsourcing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Discovery Outsourcing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarker Discovery Outsourcing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Discovery Outsourcing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomarker Discovery Outsourcing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Predictive biomarkers
- Safety biomarkers
- Prognostic biomarkers
- Others
Applications
- Biotechnology Company
- Pharmaceutical Company
- Others
Companies covered
- Laboratory Corporation of America Holdings
- GHO Capital
- ICON plc
- Agilent
- Proteome Sciences
- Charles River Laboratories.
- Eurofins Scientific
- Celerion
- Evotec
- Parexel International (MA) Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomarker Discovery Outsourcing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Predictive biomarkers
- 2.2.3 Safety biomarkers
- 2.2.4 Prognostic biomarkers
- 2.2.5 Others
- 2.3 Biomarker Discovery Outsourcing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotechnology Company
- 2.3.3 Pharmaceutical Company
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Biomarker Discovery Outsourcing Services Breakdown Data by Type
- 3.1 Global Biomarker Discovery Outsourcing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Biomarker Discovery Outsourcing Services Forecasted Market Size by Type (2027-2032)
4 Biomarker Discovery Outsourcing Services Breakdown Data by Application
- 4.1 Global Biomarker Discovery Outsourcing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Biomarker Discovery Outsourcing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomarker Discovery Outsourcing Services Market Perspective (2021-2032)
- 5.2 Global Biomarker Discovery Outsourcing Services Growth Trends by Region
- 5.2.1 Global Biomarker Discovery Outsourcing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomarker Discovery Outsourcing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Biomarker Discovery Outsourcing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Biomarker Discovery Outsourcing Services Market Dynamics
- 5.3.1 Biomarker Discovery Outsourcing Services Industry Trends
- 5.3.2 Biomarker Discovery Outsourcing Services Market Drivers
- 5.3.3 Biomarker Discovery Outsourcing Services Market Challenges
- 5.3.4 Biomarker Discovery Outsourcing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomarker Discovery Outsourcing Services Players by Revenue
- 6.1.1 Global Top Biomarker Discovery Outsourcing Services Players by Revenue (2021-2026)
- 6.1.2 Global Biomarker Discovery Outsourcing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomarker Discovery Outsourcing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomarker Discovery Outsourcing Services Head Office and Area Served
- 6.4 Global Biomarker Discovery Outsourcing Services Players, Product Type & Application
- 6.5 Global Biomarker Discovery Outsourcing Services Manufacturers Established Date
- 6.6 Global Biomarker Discovery Outsourcing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 7.2 North America Biomarker Discovery Outsourcing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 7.4 North America Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 8.2 Europe Biomarker Discovery Outsourcing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 8.4 Europe Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Biomarker Discovery Outsourcing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 10.2 South America Biomarker Discovery Outsourcing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 10.4 South America Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Biomarker Discovery Outsourcing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Laboratory Corporation of America Holdings
- 12.1.1 Laboratory Corporation of America Holdings Company Information
- 12.1.2 Laboratory Corporation of America Holdings Business Overview
- 12.1.3 Laboratory Corporation of America Holdings Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.1.4 Laboratory Corporation of America Holdings Biomarker Discovery Outsourcing Services Product Portfolio
- 12.1.5 Laboratory Corporation of America Holdings Recent Developments
- 12.2 GHO Capital
- 12.2.1 GHO Capital Company Information
- 12.2.2 GHO Capital Business Overview
- 12.2.3 GHO Capital Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.2.4 GHO Capital Biomarker Discovery Outsourcing Services Product Portfolio
- 12.2.5 GHO Capital Recent Developments
- 12.3 ICON plc
- 12.3.1 ICON plc Company Information
- 12.3.2 ICON plc Business Overview
- 12.3.3 ICON plc Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.3.4 ICON plc Biomarker Discovery Outsourcing Services Product Portfolio
- 12.3.5 ICON plc Recent Developments
- 12.4 Agilent
- 12.4.1 Agilent Company Information
- 12.4.2 Agilent Business Overview
- 12.4.3 Agilent Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.4.4 Agilent Biomarker Discovery Outsourcing Services Product Portfolio
- 12.4.5 Agilent Recent Developments
- 12.5 Proteome Sciences
- 12.5.1 Proteome Sciences Company Information
- 12.5.2 Proteome Sciences Business Overview
- 12.5.3 Proteome Sciences Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.5.4 Proteome Sciences Biomarker Discovery Outsourcing Services Product Portfolio
- 12.5.5 Proteome Sciences Recent Developments
- 12.6 Charles River Laboratories.
- 12.6.1 Charles River Laboratories. Company Information
- 12.6.2 Charles River Laboratories. Business Overview
- 12.6.3 Charles River Laboratories. Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.6.4 Charles River Laboratories. Biomarker Discovery Outsourcing Services Product Portfolio
- 12.6.5 Charles River Laboratories. Recent Developments
- 12.7 Eurofins Scientific
- 12.7.1 Eurofins Scientific Company Information
- 12.7.2 Eurofins Scientific Business Overview
- 12.7.3 Eurofins Scientific Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.7.4 Eurofins Scientific Biomarker Discovery Outsourcing Services Product Portfolio
- 12.7.5 Eurofins Scientific Recent Developments
- 12.8 Celerion
- 12.8.1 Celerion Company Information
- 12.8.2 Celerion Business Overview
- 12.8.3 Celerion Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.8.4 Celerion Biomarker Discovery Outsourcing Services Product Portfolio
- 12.8.5 Celerion Recent Developments
- 12.9 Evotec
- 12.9.1 Evotec Company Information
- 12.9.2 Evotec Business Overview
- 12.9.3 Evotec Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.9.4 Evotec Biomarker Discovery Outsourcing Services Product Portfolio
- 12.9.5 Evotec Recent Developments
- 12.10 Parexel International (MA) Corporation
- 12.10.1 Parexel International (MA) Corporation Company Information
- 12.10.2 Parexel International (MA) Corporation Business Overview
- 12.10.3 Parexel International (MA) Corporation Revenue in Biomarker Discovery Outsourcing Services Business (2021-2026)
- 12.10.4 Parexel International (MA) Corporation Biomarker Discovery Outsourcing Services Product Portfolio
- 12.10.5 Parexel International (MA) Corporation Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst